ArticleBlood cancer journal2014

Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia.

A van der Veer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.